Event Information

Event Topic:
Change Lives, One at a Time – Introduction to Autologous ex vivo HSC Gene Therapy

Event Description:
This presentation provides a high-level overview of Orchard Therapeutics, a global gene therapy company and its core technology - ex-vivo autologous hematopoietic stem cell (HSC) gene therapy. The HSC gene therapy offers a highly differentiated approach; a onetime administration with a potential for permanent rare disease correction. With over 170 patients treated, the durability of response to Orchard’s gene therapy products is out to over 18 years. Like other autologous cell and gene therapy, Orchard’s product starts and ends with patients, which presents some unique manufacturing and supply chain challenges. The company is focusing on building foundational capabilities while exploring new technologies to ensure reliable patient supply and long-term success.

Date/Time:
Date(s) - 10/13/20
8:30 am - 10:30 am

Event Location:
Zoom talk: https://us02web.zoom.us/j/85043660945:

Speaker Information

Event Speaker:
Ran Zheng

Event Speaker Title:
Chief Technical Officer

Event Speaker Company:
Orchard Therapeutics

Event Speaker Bio:

Ran Zheng is Chief Technical Officer at Orchard Therapeutics, overseeing multiple functions within technical operations including process development, manufacturing, quality, facilities and engineering, supply chain, and CMC lifecycle management. Ran has over 25 years of experience in biopharmaceutical industry. Prior to Orchard, Ran held various leadership positions in process development, manufacturing, quality and supply chain at Amgen, Genzyme and Diosynth.

Event Details

Cost:
$0

Add To Calendar